Target Price | KRW331,148.00 |
Price | KRW221,000.00 |
Potential |
49.84%
register free of charge
|
Number of Estimates | 27 |
27 Analysts have issued a price target LG Chem 2026 .
The average LG Chem target price is KRW331,148.00.
This is
49.84%
register free of charge
KRW530,000.00
139.82%
register free of charge
KRW195,000.00
11.76%
register free of charge
|
|
A rating was issued by 28 analysts: 24 Analysts recommend LG Chem to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the LG Chem stock has an average upside potential 2026 of
49.84%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion KRW | 48,916.10 | 51,344.95 |
11.46% | 4.97% | |
EBITDA Margin | 8.38% | 14.88% |
19.70% | 77.60% | |
Net Margin | -1.41% | 1.45% |
158.33% | 202.66% |
27 Analysts have issued a sales forecast LG Chem 2025 . The average LG Chem sales estimate is
This results in the following potential growth metrics:
26 Analysts have issued an LG Chem EBITDA forecast 2025. The average LG Chem EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 LG Chem Analysts have issued a net profit forecast 2025. The average LG Chem net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share KRW | -8,825.97 | 9,512.59 |
151.64% | 207.78% | |
P/E | 23.60 | |
EV/Sales | 1.00 |
9 Analysts have issued a LG Chem forecast for earnings per share. The average LG Chem EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.